000 01533 a2200409 4500
005 20250513142858.0
264 0 _c19980724
008 199807s 0 0 eng d
022 _a1078-0998
024 7 _a10.1002/ibd.3780040202
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHanauer, S B
245 0 0 _aDose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
_h[electronic resource]
260 _bInflammatory bowel diseases
_cMay 1998
300 _a79-83 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAcute Disease
650 0 4 _aAdult
650 0 4 _aAnalysis of Variance
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aColitis, Ulcerative
_xdiagnosis
650 0 4 _aColonoscopy
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aEnema
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMesalamine
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aProctocolitis
_xdiagnosis
650 0 4 _aProspective Studies
650 0 4 _aTreatment Outcome
773 0 _tInflammatory bowel diseases
_gvol. 4
_gno. 2
_gp. 79-83
856 4 0 _uhttps://doi.org/10.1002/ibd.3780040202
_zAvailable from publisher's website
999 _c9556080
_d9556080